High Mark Wealth Management LLC Centessa Pharmaceuticals PLC Transaction History
High Mark Wealth Management LLC
- $173 Million
- Q4 2024
A detailed history of High Mark Wealth Management LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, High Mark Wealth Management LLC holds 166,135 shares of CNTA stock, worth $2.86 Million. This represents 1.61% of its overall portfolio holdings.
Number of Shares
166,135
Previous 167,135
0.6%
Holding current value
$2.86 Million
Previous $2.67 Million
4.12%
% of portfolio
1.61%
Previous 1.47%
Shares
3 transactions
Others Institutions Holding CNTA
# of Institutions
106Shares Held
118MCall Options Held
5.9KPut Options Held
53K-
Medicxi Ventures Management (Jersey) LTD20MShares$344 Million73.44% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$172 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$167 Million4.42% of portfolio
-
Perceptive Advisors LLC New York, NY6.28MShares$108 Million2.62% of portfolio
-
First Light Asset Management, LLC Edina, MN5.94MShares$102 Million8.27% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.63B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...